Two CD I-NP O 0,3
methods NNS I-NP O 4,11
of IN I-PP O 12,14
formulating VBG I-VP I-KP 15,26
anionic JJ I-NP I-KP 27,34
nanocomplexes NNS I-NP I-KP 35,48
were VBD I-VP O 49,53
evaluated. JJ I-NP O 54,63

In IN I-PP O 65,67
both, NN I-NP O 68,72
nanocomplexes NNS I-NP I-KP 74,87
were VBD I-VP O 88,92
prepared VBN I-VP I-KP 93,101
in IN I-PP O 102,104
water NN I-NP O 105,110
at IN I-PP O 111,113
a DT I-NP O 114,115
range NN I-NP O 116,121
of IN I-PP O 122,124
molar JJ I-NP O 125,130
charge NN I-NP O 131,137
ratios NNS I-NP O 138,144
of IN I-PP O 145,147
L NNP I-NP O 148,149
to TO I-VP O 150,152
D NNP I-NP O 153,154
while IN I-PP O 155,160
the DT I-NP O 161,164
peptide NN I-NP O 165,172
P NNP I-NP O 173,174
to TO I-VP O 175,177
D NNP I-NP O 178,179
molar JJ I-NP O 180,185
charge NN I-NP O 186,192
ratio NN I-NP O 193,198
was VBD I-VP O 199,202
maintained VBN I-VP O 203,213
constant JJ I-NP O 214,222
at IN I-PP O 223,225
3:1. CD I-NP O 226,229

Method NNP I-NP O 231,237
1 CD I-NP O 238,239
(L:D:P): NNP I-NP O 240,247
DNA NNP I-NP I-KP 249,252
was VBD I-VP O 253,256
first RB I-VP O 257,262
added VBN I-VP I-KP 263,268
to TO I-VP O 269,271
an DT I-NP I-KP 272,274
anionic JJ I-NP I-KP 275,282
liposome NN I-NP I-KP 283,291
(LA, NNP I-NP O 292,295
LAP1 NNP I-NP I-KP 297,301
or CC O I-KP 302,304
LAP2) NNP I-NP O 305,310
and CC O O 311,314
incubated VBN I-VP I-KP 315,324
for IN I-PP O 325,328
15min CD I-NP O 329,334
at IN I-PP O 335,337
room NN I-NP O 338,342
temperature NN I-NP O 343,354
and CC O O 355,358
then RB O O 359,363
the DT I-NP O 364,367
peptide NN I-NP O 368,375
was VBD I-VP O 376,379
added VBN I-VP I-KP 380,385
with IN I-PP O 386,390
rapid JJ I-NP O 391,396
mixing NN I-NP O 397,403
and CC O O 404,407
incubated VBN I-VP I-KP 408,417
at IN I-PP O 418,420
room NN I-NP O 421,425
temperature NN I-NP O 426,437
for IN I-PP O 438,441
a DT I-NP O 442,443
further JJ I-NP O 444,451
20min; CD I-NP O 452,457
Method NNP I-NP O 459,465
2 CD I-NP O 466,467
(P:D:L): VBD I-VP O 468,475
the DT I-NP O 477,480
peptide NN I-NP I-KP 481,488
was VBD I-VP O 489,492
added VBN I-VP I-KP 493,498
to TO I-VP O 499,501
the DT I-NP O 502,505
DNA NN I-NP O 506,509
and CC O O 510,513
incubated VBD I-VP I-KP 514,523
for IN I-PP O 524,527
15min CD I-NP O 528,533
at IN I-PP O 534,536
room NN I-NP O 537,541
temperature NN I-NP O 542,553
and CC O O 554,557
then RB O O 558,562
liposome VB I-VP I-KP 563,571
was VBD I-VP O 572,575
added VBN I-VP I-KP 576,581
with IN I-PP O 582,586
rapid JJ I-NP O 587,592
mixing NN I-NP O 593,599
and CC O O 600,603
incubated VBN I-VP I-KP 604,613
at IN I-PP O 614,616
room NN I-NP O 617,621
temperature NN I-NP O 622,633
for IN I-PP O 634,637
a DT I-NP O 638,639
further JJ I-NP O 640,647
20min. CD I-NP O 648,653

Irrespective NNP I-NP O 655,667
of IN I-PP O 668,670
the DT I-NP O 671,674
method NN I-NP O 675,681
of IN I-PP O 682,684
order NN I-NP O 685,690
of IN I-PP O 691,693
mixing, NN I-NP O 694,700
all DT I-NP O 702,705
molar JJ I-NP O 706,711
charge NN I-NP O 712,718
ratios NNS I-NP O 719,725
in IN I-PP O 726,728
this DT I-NP O 729,733
study NN I-NP O 734,739
refer VBP I-VP O 740,745
to TO I-VP O 746,748
L:P:D. NNP I-NP O 749,754
Cationic NNP I-NP O 756,764
formulations NNS I-NP O 765,777
LPD NNP I-NP I-KP 778,781
and CC O O 782,785
LCPRGPD NNP I-NP I-KP 786,793
were VBD I-VP O 794,798
prepared VBN I-VP O 799,807
in IN I-PP O 808,810
the DT I-NP O 811,814
order NN I-NP O 815,820
L:P:D NNP I-NP O 821,826
as IN I-PP O 827,829
described JJ I-NP O 830,839
previously; NN I-NP O 840,850
first, VBD I-VP O 852,857
the DT I-NP O 859,862
peptide NN I-NP O 863,870
was VBD I-VP O 871,874
added VBN I-VP I-KP 875,880
to TO I-VP O 881,883
the DT I-NP O 884,887
liposome JJ I-NP O 888,896
DOTMA/DOPE NNP I-NP O 897,907
or CC O O 908,910
LCPRG NNP I-NP I-KP 911,916
followed VBN I-NP O 917,925
by IN I-PP O 926,928
addition NN I-NP O 929,937
of IN I-PP O 938,940
the DT I-NP O 941,944
DNA NN I-NP I-KP 945,948
with IN I-PP O 949,953
rapid JJ I-NP I-KP 954,959
mixing NN I-NP I-KP 960,966
and CC O I-KP 967,970
incubated VBN I-VP I-KP 971,980
for IN I-PP O 981,984
30min CD I-NP O 985,990
at IN I-PP O 991,993
room NN I-NP O 994,998
temperature NN I-NP O 999,1010
to TO I-VP O 1011,1013
allow VB I-VP O 1014,1019
for IN I-PP O 1020,1023
complex JJ I-NP O 1024,1031
formation NN I-NP O 1032,1041
[30]. NN I-NP O 1042,1046

The DT I-NP O 1048,1051
nanocomplexes NNS I-NP O 1052,1065
prepared VBD I-VP O 1066,1074
were VBD I-VP O 1075,1079
termed VBN I-VP O 1080,1086
LPD NNP I-NP I-KP 1087,1090
(liposome NNP I-NP O 1091,1100
DOTMA/DOPE), NNP I-NP O 1101,1112
LADP NNP I-NP I-KP 1114,1118
and CC O O 1119,1122
PDLA NNP I-NP I-KP 1123,1127
(liposome NNP I-NP O 1128,1137
LA), NNP I-NP O 1138,1141
PDLAP1 NNP I-NP I-KP 1143,1149
(liposome NNP I-NP O 1150,1159
LAP1), NNP I-NP O 1160,1165
PDLAP2 NNP I-NP I-KP 1167,1173
(liposome NNP I-NP O 1174,1183
LAP2), NNP I-NP O 1184,1189
PDLAPRG NNP I-NP I-KP 1191,1198
(liposome NNP I-NP O 1199,1208
LAPRG) NNP I-NP O 1209,1215
and CC O O 1216,1219
LCPRGPD NNP I-NP I-KP 1220,1227
(liposome NNP I-NP O 1228,1237
LCPRG). NNP I-NP O 1238,1244

